Skip to main content
Equibles

600332 · 广州白云山医药集团股份有限公司 · Debt

Use 600332 with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research 600332.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
19.6900 CNY -0.0300 (-0.15%) At close · Oct 8
Rebalance outlook locked
Market Cap
32.06B CNY
Shares
1.63B

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Bonds payable 2026-06-30 CNY 610,066,192 Interim report filed 2026-08-22
Lease liabilities 2026-06-30 CNY 404,533,251 Interim report filed 2026-08-22
Long-term borrowings 2026-06-30 CNY 4,475,589,195 Interim report filed 2026-08-22
Short-term borrowings 2026-06-30 CNY 12,573,408,502 Interim report filed 2026-08-22
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.